Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma

23 Jan 2007

Abstract excerpt

Despite advances in our cellular and molecular knowledge, hepatocellular carcinoma (HCC) remains one of the major public health problems throughout the world. It is now known to be highly heterogeneous: it encompasses various pathological entities and a wide range of clinical behaviors, and is underpinned by a complex array of gene alterations that affect supra-molecular processes.Four families of HCC tumour...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glycosylation and Glycoproteins Research
Share to Immunotherapy and Immune Responses
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17244360
DOI: 10.1186/1479-5876-5-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinomaPMID 17244360Read ↗

Tumour-associated antigens and their anti-cancer applicationsSemantic proximity Read ↗

Emerging evidence of molecular biomarkers in hepatocellular carcinoma.Semantic proximity Read ↗

Identification of two novel CT antigens and their capacity to elicit antibody response in hepatocellular carcinoma patientsSemantic proximity Read ↗

Alpha-fetoprotein: Past, present, and futureSemantic proximity Read ↗

Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert reviewSemantic proximity Read ↗

Mucins: the Old, the New and the Promising Factors in Hepatobiliary CarcinogenesisSemantic proximity Read ↗

Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver GenesSemantic proximity Read ↗

Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Biology and significance of alpha‐fetoprotein in hepatocellular carcinomaSemantic proximity Read ↗

[Tumor antigens].Semantic proximity Read ↗

Proteome Expression Profile for Red Blood Cells Enables Diagnostics for Hepatocellular CarcinomaSemantic proximity Read ↗

TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.